Molecular mechanisms of cancer progression
University of Liverpool researchers work with colleagues around the world to understand the mechanisms that underpin cancer development and progression that can be used as a target for drugs and therapies.
Liverpool Experimental Cancer Medicine Centre
The Liverpool ECMC, funded by CRUK and the NIHR, is a collaboration between the University of Liverpool and The Clatterbridge Cancer Centre NHS Foundation Trust.
Tumour microenvironment & Immuno-oncology
Our overarching aim is the preclinical development and early phase clinical testing of strategies to induce anti-tumour immune responses in patients. With a strong collaborative approach, we are working with surgeons, oncologists and researchers across the region, nationally and internationally.
With our team science approach, we have established a programme of translational and clinical research in haemato-oncology. The recent reconfiguration of the clinical service enables us to take our research to the next level and bring even more benefit for our patients.
Liverpool Head and Neck Centre
Head and neck cancer is a devastating disease and is a major healthcare problem in the Liverpool region. The Liverpool Head and Neck Centre (LHNC) combines internationally recognised clinical and research strengths to deliver research-led improvements in the quality and safety of patient care.
Liverpool Pancreatic and Hepatobiliary Research
We bring together our excellent clinical, translational and basic research under an overarching collaboration aiming to detect cancer early and improve life for those at risk or affected by pancreatic and hepatobiliary disease.
Cancer and COVID-19
Liverpool researchers have come together to research the effects of COVID-19 on cancer patients. People with cancer are known to be more at risk of severe COVID-19. Research in Liverpool addresses which cancer patients are most vulnerable and which treatments carry the most risk.
Ocular Oncology and Ophthalmic Pathology
The Liverpool-Ocular-Oncology-Research-Group based at the University of Liverpool, comprises an internationally-recognised team of basic researchers, diagnostic pathologists, ocular oncologists, medical oncologists, clinical statisticians and students.
Training and Development
At the University of Liverpool, developing the future leaders in cancer research is a priority and we support our students and staff at all stages of their training and development with innovative approaches and unique infrastructure.